Skip to main content

Table 5 Knowledge of injectable contraceptives retention from posttest to 9 months among CPs and Tier 2 PPMVs (n = 485)

From: The role of job aids in supporting task sharing family planning services to community pharmacists and patent proprietary medicine vendors in Kaduna and Lagos, Nigeria

 

Posttest (n = 485)

9 months later, among those that answered correctly at posttest

Syringe and needle are used to administer Depo-Provera

 

(n = 420)

  Incorrect

12.2

7.9

  Correct

86.6

92.1

Depo-Provera is administered intramuscularly

 

(n = 451)

  Incorrect

7.0

15.7

  Correct

93.0

84.3

Depo-Provera can be administered in buttocks, deltoid, thighs

 

(n = 385)

  Incorrect

20.6

19.5

  Correct

79.4

80.5

Depo-Provera is administered every 3 months

 

(n = 460)

  Incorrect

5.2

3.5

  Correct

94.8

96.5

Uniject is used to administer Sayana Press

 

(n = 429)

  Incorrect

8.7

4.9

  Correct

88.5

95.1

Sayana Press is administered subcutaneously

 

(n = 441)

  Incorrect

9.1

9.3

  Correct

90.9

90.7

Sayana Press can be administered on thighs, abdominal wall, back of the arm

 

(n = 260)

  Incorrect

44.7

48.1

  Correct

53.6

51.9

Sayana Press is administered every 3 months

 

(n = 416)

  Incorrect

14.2

9.6

  Correct

85.8

90.4

Depo Provera/Sayana Press have same active drug

 

(n = 429)

  Incorrect

11.5

4.2

  Correct

88.5

95.8

Sharp box contents disposed at health facility

 

(n = 205)

  Incorrect

57.7

17.6

  Correct

42.3

82.4

Injectables stored at room temperature and out of direct sunlight

 

(n = 448)

  Incorrect

4.7

7.1

  Correct

92.4

92.9